X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-02 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $33.91 | -30,000 | 649,429 | -4% | -$1,017,430 | |||||
| DM | 2023-01-30 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $34.48 | -45,000 | 649,429 | -6% | -$1,551,637 | |||||
| DM | 2023-01-26 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $35.32 | -55,000 | 649,429 | -8% | -$1,942,336 | |||||
| DM | 2023-01-23 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $33.12 | -60,000 | 528,129 | -10% | -$1,987,473 | |||||
| D | 2023-01-23 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale+OE | $34.19 | -20,000 | 5,947 | -77% | -$683,878 | |||||
2023-01-23 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $34.48 | -67,500 | 76,926 | -47% | -$2,327,630 | ||||||
| D | 2023-01-23 | PLRX | Cummings Keith Lamont | CFO | S - Sale+OE | $35.00 | -30,000 | 84,424 | -26% | -$1,050,000 | |||||
| DM | 2023-01-06 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $19.07 | -20,000 | 543,129 | -4% | -$381,413 | |||||
| DM | 2023-01-03 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $19.20 | -30,000 | 543,129 | -5% | -$575,892 | |||||
2022-12-22 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $19.38 | -2,928 | 5,947 | -33% | -$56,731 | ||||||
2022-12-20 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $19.10 | -9,643 | 80,424 | -11% | -$184,204 | ||||||
2022-12-20 | PLRX | Coulie Bernard | Pres, CEO | S - Sale | $19.10 | -34,212 | 543,129 | -6% | -$653,531 | ||||||
2022-12-20 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $19.10 | -10,887 | 144,426 | -7% | -$207,968 | ||||||
2022-12-20 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $19.10 | -4,719 | 8,875 | -35% | -$90,144 | ||||||
2022-12-20 | PLRX | Hull Hans | Chief Business Officer | S - Sale | $19.10 | -8,748 | 169,982 | -5% | -$167,108 | ||||||
2022-10-25 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $25.05 | -5,000 | 133,437 | -4% | -$125,241 | ||||||
| D | 2022-09-12 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $22.54 | -12,502 | 508,590 | -2% | -$281,851 | |||||
2022-07-11 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $20.00 | -3,000 | 138,436 | -2% | -$60,000 | ||||||
| DM | 2022-07-11 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $22.50 | -27,498 | 508,590 | -5% | -$618,705 | |||||
2021-06-18 | PLRX | Lefebvre Eric | Chief Medical Officer | S - Sale | $28.87 | -12,500 | 137,080 | -8% | -$360,821 | ||||||
2021-06-14 | PLRX | Coulie Bernard | Pres, CEO | S - Sale | $33.03 | -4,000 | 504,157 | -1% | -$132,102 | ||||||
2021-05-14 | PLRX | Coulie Bernard | Pres, CEO | S - Sale | $28.64 | -3,500 | 508,157 | -1% | -$100,224 | ||||||
| D | 2021-04-14 | PLRX | Coulie Bernard | Pres, CEO | S - Sale+OE | $30.33 | -3,500 | 511,657 | -1% | -$106,161 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |